Pan-cancer assessment of the impact of intronic variants on cancer development and progression

被引：0

作者：

Safonov, A. ^{[1
]}

Mehine, M. ^{[2
]}

Ceyhan-Birsoy, O. ^{[3
]}

Brown, D. ^{[4
]}

Bandlamudi, C.

Forbes, A. ^{[6
]}

Gazzo, A. ^{[4
]}

Selenica, P. ^{[4
]}

Shen, R. ^{[7
]}

Khurana, E. ^{[8
]}

Norton, L. ^{[9
]}

Solit, D. ^{[1
]}

Chandarlapaty, S. ^{[1
]}

Razavi, P. ^{[1
]}

Robson, M. ^{[1
]}

Weigelt, B. ^{[5
]}

Berger, M. ^{[10
]}

Ladanyi, M. ^{[11
]}

Reis-Filho, J. S. ^{[5
]}

Mandelker, D. ^{[5
]}

机构：

[1] MSKCC Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, Clin Genet, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Pathol & Lab Med, New York, NY USA

[5] MSKCC Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA

[6] Weill Cornell Med Coll, Weill Cornell Med Sandra & Edward Meyer Canc Ctr, New York, NY USA

[7] Mem Sloan Kettering Canc Ctr, Biostat, New York, NY USA

[8] Weill Cornell Med Sandra & Edward Meyer Canc Ctr, Inst Computat Biomed, New York, NY USA

[9] Mem Sloan Kettering Evelyn H Lauder Breast Ctr, Dept Med, New York, NY USA

[10] Mem Sloan Kettering Canc Ctr, Mol Diagnost Serv, New York, NY USA

[11] MSKCC Mem Sloan Kettering Canc Ctr, Mol Oncol, New York, NY USA

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1259

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2231O

引用

页码：S1149 / S1149

页数：1

共 50 条

[1] A pan-cancer interrogation of intronic polyadenylation and its association with cancer characteristics
Liu, Liang
Sun, Peiqing
Zhang, Wei
BRIEFINGS IN BIOINFORMATICS, 2024, 25 (05)
[2] The role of TAOK3 in cancer progression and development as a prognostic marker: A pan-cancer analysis study
Alasiri, Glowi
Alrfaei, Bahauddeen
Alaseem, Ali M.
Alkhamees, Osama A.
Aldali, Jehad A.
Aljehani, Ala M.
Alfahed, Abdulaziz
Aziz, Mohammad Azhar
Almuhaini, Ghadir
Alshehri, Mana M.
SAUDI PHARMACEUTICAL JOURNAL, 2024, 32 (03)
[3] Development of cancer prognostic signature based on pan-cancer proteomics
Huang, Weiguo
Chen, Jianhui
Weng, Wanqing
Xiang, Yukai
Shi, Hongqi
Shan, Yunfeng
BIOENGINEERED, 2020, 11 (01) : 1368 - 1381
[4] A pan-cancer analysis of progression mechanisms and drug sensitivity in cancer cell lines
Fleck, Julia L.
Pavel, Ana B.
Cassandras, Christos G.
MOLECULAR OMICS, 2019, 15 (06) : 399 - 405
[5] A pan-cancer atlas
Nawy, Tal
NATURE METHODS, 2018, 15 (06) : 407 - 407
[6] A pan-cancer atlas
Tal Nawy
Nature Methods, 2018, 15 : 407 - 407
[7] EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer
Zhang, Jun
Yang, Jing
Li, Xing
Mao, Lin
Zhang, Yan
Liu, Yi
Bao, Yindi
MOLECULAR GENETICS AND GENOMICS, 2024, 299 (01)
[8] Dichotomous intronic polyadenylation profiles reveal multifaceted gene functions in the pan-cancer transcriptome
Sun, Jiao
Kim, Jin-Young
Jun, Semo
Park, Meeyeon
de Jong, Ebbing
Chang, Jae-Woong
Cheng, Sze
Fan, Deliang
Chen, Yue
Griffin, Timothy J.
Lee, Jung-Hee
You, Ho Jin
Zhang, Wei
Yong, Jeongsik
EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (10): : 2145 - 2161
[9] Contribution of Pathogenic Variants in Genes Predisposing to Colorectal Cancer by Pan-Cancer Panel Testing
Eiengard, Frida
Rohlin, Anna
Olausson, Torbjorn
Lundstam, Ulf
Nordling, Margareta
EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 386 - 386
[10] FusionNW, a potential clinical impact assessment of kinases in pan-cancer fusion gene network
Yang, Chengyuan
Kumar, Himansu
Kim, Pora
BRIEFINGS IN BIOINFORMATICS, 2024, 25 (02)

← 1 2 3 4 5 →